MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid tumour that affects around 2,000 people in the US each year. The green ...

As Amgen waits for an FDA decision on a second indication for its B cell-depleting therapy Uplizna, it has new data suggesting a third may be coming down the pipe. New data from the phase 3 MINT trial ...

Skin cancer is cancer that begins in skin cells and typically causes unusual growth or changes. Some types of skin cancer can spread to other parts of the body. Skin cancer is the most common form of ...

Radioactivity is a part of our earth - it has existed all along. Naturally occurring radioactive materials are present in its crust, the floors and walls of our homes, schools, or offices and in the ...